Pregnancy: US Pregnancy Category: C.
Either studies in animals have revealed adverse effects on the fetus (teratogenic or embryocidal or other) when administered systemically at relatively low dosages and there are no controlled studies in women or studies in women and animals are not available. Drug should be given only if the potential benefit justifies the potential risk to the fetus. In pregnant patients, do not use extensively; do not use in large amounts or for prolonged periods of time.
Labor and delivery: Data is not available.
Lactation: It is not known whether topical triamcinolone could result in sufficient systemic absorption to produce detectable quantities in breast milk. Nevertheless, exercise caution when administering topical triamcinolone to a nursing mother.